I’ve really enjoyed day 2 of ISSCR 2014. So far this day has already packed in a slew of great talks both in the lecture halls and outside one-on-one with old friends and new ones. How great is that? I’ll focus on just a few highlights to keep it concise. Dubious stem cell clinics and […]
ISSCR 2014 Day 2: Navigating Balanced Stem Cell Path to Clinic Read More »
What would be the World Cup of Stem Cells? This morning at ISSCR 2014 in Vancouver things kicked off in an exciting way, kind of akin to a World Cup soccer/football match for fans of stem cells. Azim Surani (pictured at right) received the McEwen Award for his innovative research on germ cell fate and epigenetic
Kick Off of ISSCR 2014: Some Top Highlights Of World Cup of Stem Cells Read More »
Is Neuralstem flirting with noncompliance via a Right To Try Law in Colorado? Colorado is an independent-minded state. For example, it is one of only a few states including Washington State with legalized marijuana use. More recently, Colorado passed a new law supported by the ultra-conservative Goldwater Institute, the so-called Right To Try Law. This law
Neuralstem flirting with noncompliance via Right To Try Law? Read More »
I did a brief email Q&A interview with Dr. Bob Lanza of Advanced Cell Technology (ACT) on their new hES MSCs pre-clinical data for Multiple Sclerosis. I discussed the paper itself in a concise review yesterday here. Thanks to Dr. Lanza for doing the interview. 1. Were you surprised at the fact that the therapeutic
Interview with Bob Lanza on new ACT MSCs for MS paper Read More »
There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells to treat mice with an MS-like condition. They published a new paper in the journal Stem Cell Reports entitled “Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of
Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS Read More »
It’s been an important week for stem cells. Although I’ve been busy working on multiple grants and papers, when I take a break I like to read up on what’s been going on with stem cells. What are the top stem cell stories and headlines of the week? CIRM awarded Asterias (a subsidiary of BioTime)
TGIF stem cell headlines of week: Asterias, lasers, immunity, & more Read More »
Two stem cell papers riddled with errors, with figures that resulted from potential misconduct, with plagiarism, and with other serious problems remain uncorrected and unretracted in the prestigious journal Nature. It is well past time for the journal to editorially retract them. It was about four months ago that Nature published the two astonishing STAP papers reporting the
Past Time for Nature to Retract STAP Cell Pubs, Open up on Review Problems Read More »
When bioethicist Arthur Caplan talks about stem cells, people pay close attention and for good reason. Caplan has provided important perspectives on the stem cell field over the years. For example, you can see a guest post on this blog here about human cloning. However, in my post today I respectfully discuss how I disagree with several parts of this week’s piece by
Arthur Caplan Article on Bogus Stem Cell Research: Some Different Views Read More »
What happens if we start using induced pluripotent stem (iPS) cells clinically in humans? A cool new paper recently came out that gets us closer to being able to predict an answer. It’s an important question as iPS cell-derived cellular products are getting closer to clinical use. For example, the first iPS cell-based clinical trial
Cool, encouraging new preclinical study on monkey stem cells Read More »
Sometimes there is so much craziness and outright bad stuff going on out there around the world related to stem cells that we can lose sight of all the good news and encouraging developments as well. I think the new paper (Chen, et al.) from a team led by Drs. Lane and Loring is good news.
What are important, recent stem cell good news stories? Read More »